Cytoplasmic CaMKIIδ-B prevents myocardial recovery in heart failure
Martin, T. G.; Hunt, D. R.; Ebmeier, C. C.; Dhand, A. P.; Alamana, C.; Cleveland, J. C.; Graw, S. L.; Bruner, S.; Bristow, M. R.; Mestroni, L.; Taylor, M. R.; Burdick, J. A.; Ambardekar, A. V.; Buttrick, P. M.; Leinwand, L. A.
Show abstract
Restoration of cardiac function in patients with advanced heart failure is rare, and the molecular processes that regulate recovery are unknown. To identify potential mechanisms, we studied paired myocardial samples before and after left ventricular assist device therapy, where significant cardiac functional recovery occurred in [~]25% of patients. We found that expression of the nuclear B isoform of Ca2+/calmodulin-dependent protein kinase II{delta} (CaMKII{delta}-B) inversely correlated with recovery. Furthermore, increased phosphorylation near the CaMKII{delta}-B nuclear localization signal in non-responders prevented its auto-activation dependent nuclear translocation. Expression of a cytoplasm-restricted CaMKII{delta}-B in cardiomyocytes dramatically remodeled the phospho-proteome and impaired contractility, while a nuclear-competent version did not. Modulating CaMKII{delta} subcellular localization may thus represent a therapeutic strategy for advanced heart failure.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Targeted glycophagy ATG8 therapy reverses diabetic heart disease in mice and in human engineered cardiac tissues 95%
- Tbx5 maintains atrial identity by regulating an atrial enhancer network 95%
- Ablation of three major phospho-sites in RyR2 preserves the global adrenergic response but creates an arrhythmogenic substrate 93%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.